-
To_profile_the_landscape_of_sebaceous_tumours___RNA
Study
EGAS00001007803
-
MethylationEPIC BeadChip samples of pre- and post-5ZA-treated head and neck cancer patients refractory to anto-PD-1 therapy
Study
EGAS00001007998
-
Phosphoproteomics adds value to treatment recommendations in molecular tumor boards
Study
EGAS00001007891
-
The University of Hong Kong Intestinal Metaplasia Organoids Study
Study
EGAS00001007899
-
Organoid drug profiling identifies methotrexate as a therapy for SCCOHT, a rare pediatric cancer
Study
EGAS00001007911
-
Multi-Layered Molecular Profiling Informs the Diagnosis and Targeted Therapy of Desmoplastic Small Round Cell Tumor
Study
EGAS00001007934
-
Integrated genomic analysis for HCC
Study
EGAS00001007957
-
Detection of cancers three years prior to diagnosis using plasma cell-free DNA
Study
EGAS00001008068
-
Organoid_Derivation_Project___GRCh38___TGS
Study
EGAS00001007349
-
A standardised framework for robust fragmentomic feature extraction from cell-free DNA sequencing data
Study
EGAS00001008051
-
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma
Study
EGAS00001008059
-
This study generated Oxford Nanopore long read sequencing data of cancer cell line mixtures for validating long-read variant calls in cancer genomics
Study
EGAS00001008107
-
Selective targeting of TBXT with DARPins identifies regulatory networks and therapeutic vulnerabilities in chordoma
Study
EGAS00001008140
-
Single cell TCRseq data fromTIL and non-TIL expanded TRACERx samples in the manuscript Bulk TCRseq from TRACERx samples from 'Subclonal immune evasion in non-small cell lung cancer'
Study
EGAS00001008161
-
Transcriptomic predictors of survival for palbociclib + endocrine therapy vs. capecitabine in aromatase inhibitor-resistant breast cancer from GEICAM/2013-02 PEARL
Study
EGAS00001008177
-
Cold Ischemia Study
Study
EGAS00001008233
-
Colorectal Microenvironment Spatial Mapping
Study
EGAS00001008254
-
Whole genome sequencing of tumor samples from advanced pre-treated NSCLC patients recruited in a phase I/II single-arm trial utilising CVA21, an oncolytic coxsackie virus, in combination with pembrolizumab.
Study
EGAS00001008258
-
Endocrine therapy reprogramming of breast cancer facilitates metastatic escape via upregulation of P-Rex1/Rac1 signalling
Study
EGAS00001008353
-
Sequencing data for oesophageal and related samples - Mourikis et al (RNA)
Dataset
EGAD00001004776
-
Genome and transcriptome sequence data from a pancreatic ductal adenocarcinoma patient
Dataset
EGAD00001005901
-
Genome and transcriptome sequence data from a retroperitoneal leiomyosarcoma patient
Dataset
EGAD00001002583
-
A comprehensive characterisation and analysis of human breast cancers through whole-genome sequencing
Dataset
EGAD00001002740
-
WES of multi-regional CRC samples
Dataset
EGAD00001006165
-
Genome and transcriptome sequence data from a diffuse large B-cell lymphoma patient
Dataset
EGAD00001004906